BE477344A - - Google Patents
Info
- Publication number
- BE477344A BE477344A BE477344DA BE477344A BE 477344 A BE477344 A BE 477344A BE 477344D A BE477344D A BE 477344DA BE 477344 A BE477344 A BE 477344A
- Authority
- BE
- Belgium
- Prior art keywords
- sep
- phenyl
- radical
- piperidyl
- alkyl
- Prior art date
Links
- -1 cycloaliphatic Chemical group 0.000 claims description 72
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 45
- 238000006243 chemical reaction Methods 0.000 claims description 15
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims description 13
- 238000000034 method Methods 0.000 claims description 13
- 239000000203 mixture Substances 0.000 claims description 13
- 125000000217 alkyl group Chemical group 0.000 claims description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 9
- 239000007818 Grignard reagent Substances 0.000 claims description 8
- 150000004795 grignard reagents Chemical class 0.000 claims description 8
- 229910052736 halogen Chemical group 0.000 claims description 8
- 150000002576 ketones Chemical class 0.000 claims description 7
- 238000002360 preparation method Methods 0.000 claims description 6
- 239000002904 solvent Substances 0.000 claims description 6
- 125000003710 aryl alkyl group Chemical group 0.000 claims description 5
- 125000005936 piperidyl group Chemical group 0.000 claims description 5
- 125000001302 tertiary amino group Chemical group 0.000 claims description 5
- 238000010438 heat treatment Methods 0.000 claims description 4
- 238000010992 reflux Methods 0.000 claims description 4
- 238000001816 cooling Methods 0.000 claims description 3
- 125000005265 dialkylamine group Chemical group 0.000 claims description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 3
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 claims description 3
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 3
- 230000003301 hydrolyzing Effects 0.000 claims description 2
- 125000000468 ketone group Chemical group 0.000 claims description 2
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 2
- 125000004432 carbon atoms Chemical group C* 0.000 claims 2
- 125000005843 halogen group Chemical group 0.000 claims 2
- 238000007259 addition reaction Methods 0.000 claims 1
- 229920001098 polystyrene-block-poly(ethylene/propylene) Polymers 0.000 description 216
- RTZKZFJDLAIYFH-UHFFFAOYSA-N diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 32
- 239000000243 solution Substances 0.000 description 30
- VEXZGXHMUGYJMC-UHFFFAOYSA-N HCl Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 26
- 150000001875 compounds Chemical class 0.000 description 24
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 18
- 239000007787 solid Substances 0.000 description 13
- 238000007792 addition Methods 0.000 description 11
- 239000000155 melt Substances 0.000 description 10
- 239000011541 reaction mixture Substances 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 238000003756 stirring Methods 0.000 description 8
- FYYHWMGAXLPEAU-UHFFFAOYSA-N magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 7
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 6
- JUJWROOIHBZHMG-UHFFFAOYSA-N pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 5
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- 239000002244 precipitate Substances 0.000 description 5
- 238000001953 recrystallisation Methods 0.000 description 5
- 150000003509 tertiary alcohols Chemical class 0.000 description 5
- DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 description 4
- 229930006677 A03BA01 - Atropine Natural products 0.000 description 4
- JGOAIQNSOGZNBX-UHFFFAOYSA-N Adiphenine Chemical compound C=1C=CC=CC=1C(C(=O)OCCN(CC)CC)C1=CC=CC=C1 JGOAIQNSOGZNBX-UHFFFAOYSA-N 0.000 description 4
- RKUNBYITZUJHSG-SPUOUPEWSA-N Atropine Chemical compound O([C@H]1C[C@H]2CC[C@@H](C1)N2C)C(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-SPUOUPEWSA-N 0.000 description 4
- 229960000396 Atropine Drugs 0.000 description 4
- ANRQGKOBLBYXFM-UHFFFAOYSA-M Phenylmagnesium bromide Chemical compound Br[Mg]C1=CC=CC=C1 ANRQGKOBLBYXFM-UHFFFAOYSA-M 0.000 description 4
- 229960004512 adiphenine Drugs 0.000 description 4
- 230000002921 anti-spasmodic Effects 0.000 description 4
- 238000009835 boiling Methods 0.000 description 4
- 239000000812 cholinergic antagonist Substances 0.000 description 4
- 230000000875 corresponding Effects 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000006460 hydrolysis reaction Methods 0.000 description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 4
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 4
- 239000003921 oil Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 125000003944 tolyl group Chemical group 0.000 description 4
- BDERNNFJNOPAEC-UHFFFAOYSA-N 1-propanol Substances CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 3
- 208000005392 Spasm Diseases 0.000 description 3
- HWHLPVGTWGOCJO-UHFFFAOYSA-N Trihexyphenidyl Chemical compound C1CCCCC1C(C=1C=CC=CC=1)(O)CCN1CCCCC1 HWHLPVGTWGOCJO-UHFFFAOYSA-N 0.000 description 3
- JUUNYTVCJDPKMB-UHFFFAOYSA-M [Br-].CC(C)CC[Mg+] Chemical compound [Br-].CC(C)CC[Mg+] JUUNYTVCJDPKMB-UHFFFAOYSA-M 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- 239000003610 charcoal Substances 0.000 description 3
- 230000003226 decolorizating Effects 0.000 description 3
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 238000005755 formation reaction Methods 0.000 description 3
- 230000000968 intestinal Effects 0.000 description 3
- 125000005956 isoquinolyl group Chemical group 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- IZTHVPMGJIGDKL-UHFFFAOYSA-N 1-cyclohexyl-3-(diethylamino)-1-phenylpropan-1-ol;hydrochloride Chemical compound Cl.C=1C=CC=CC=1C(O)(CCN(CC)CC)C1CCCCC1 IZTHVPMGJIGDKL-UHFFFAOYSA-N 0.000 description 2
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 2
- ZFUOEDJFDJBWCT-UHFFFAOYSA-N 3-(diethylamino)-1,1-diphenylpropan-1-ol;hydrochloride Chemical compound Cl.C=1C=CC=CC=1C(O)(CCN(CC)CC)C1=CC=CC=C1 ZFUOEDJFDJBWCT-UHFFFAOYSA-N 0.000 description 2
- QARVLSVVCXYDNA-UHFFFAOYSA-N Bromobenzene Chemical compound BrC1=CC=CC=C1 QARVLSVVCXYDNA-UHFFFAOYSA-N 0.000 description 2
- UNFUYWDGSFDHCW-UHFFFAOYSA-N Cyclohexyl chloride Chemical compound ClC1CCCCC1 UNFUYWDGSFDHCW-UHFFFAOYSA-N 0.000 description 2
- 210000000936 Intestines Anatomy 0.000 description 2
- 230000003444 anaesthetic Effects 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- UHOVQNZJYSORNB-UHFFFAOYSA-N benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 2
- UXVMQQNJUSDDNG-UHFFFAOYSA-L cacl2 Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- 125000004914 dipropylamino group Chemical group C(CC)N(CCC)* 0.000 description 2
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 125000004185 ester group Chemical group 0.000 description 2
- 150000002367 halogens Chemical group 0.000 description 2
- 150000003840 hydrochlorides Chemical class 0.000 description 2
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 2
- LWLPYZUDBNFNAH-UHFFFAOYSA-M magnesium;butane;bromide Chemical compound [Mg+2].[Br-].CCC[CH2-] LWLPYZUDBNFNAH-UHFFFAOYSA-M 0.000 description 2
- FRIJBUGBVQZNTB-UHFFFAOYSA-M magnesium;ethane;bromide Chemical compound [Mg+2].[Br-].[CH2-]C FRIJBUGBVQZNTB-UHFFFAOYSA-M 0.000 description 2
- IUYHWZFSGMZEOG-UHFFFAOYSA-M magnesium;propane;chloride Chemical compound [Mg+2].[Cl-].C[CH-]C IUYHWZFSGMZEOG-UHFFFAOYSA-M 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 125000001624 naphthyl group Chemical group 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 150000003333 secondary alcohols Chemical class 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 230000002194 synthesizing Effects 0.000 description 2
- 230000001225 therapeutic Effects 0.000 description 2
- IECCHUISCGCKKS-UHFFFAOYSA-N 1,1-diphenyl-3-piperidin-1-ylpropan-1-ol;hydrochloride Chemical compound Cl.C=1C=CC=CC=1C(C=1C=CC=CC=1)(O)CCN1CCCCC1 IECCHUISCGCKKS-UHFFFAOYSA-N 0.000 description 1
- MPPPKRYCTPRNTB-UHFFFAOYSA-N 1-Bromobutane Chemical compound CCCCBr MPPPKRYCTPRNTB-UHFFFAOYSA-N 0.000 description 1
- YXZFFTJAHVMMLF-UHFFFAOYSA-N 1-bromo-3-methylbutane Chemical compound CC(C)CCBr YXZFFTJAHVMMLF-UHFFFAOYSA-N 0.000 description 1
- AMHOPTNGSNYSBL-UHFFFAOYSA-N 1-cyclohexylpropan-1-one Chemical compound CCC(=O)C1CCCCC1 AMHOPTNGSNYSBL-UHFFFAOYSA-N 0.000 description 1
- XCXFLKLOXBGAEP-UHFFFAOYSA-N 1-phenyl-3-piperidin-1-ylpropan-1-ol Chemical compound C=1C=CC=CC=1C(O)CCN1CCCCC1 XCXFLKLOXBGAEP-UHFFFAOYSA-N 0.000 description 1
- PVBUTZWGEJHWSJ-UHFFFAOYSA-N 2-morpholin-4-yl-1-phenylpropan-1-one Chemical compound C=1C=CC=CC=1C(=O)C(C)N1CCOCC1 PVBUTZWGEJHWSJ-UHFFFAOYSA-N 0.000 description 1
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
- OSYUYPKUXLFHIU-UHFFFAOYSA-N 3-phenyl-1-piperidin-1-ylheptan-3-ol Chemical compound C=1C=CC=CC=1C(O)(CCCC)CCN1CCCCC1 OSYUYPKUXLFHIU-UHFFFAOYSA-N 0.000 description 1
- SFPOWKMTUKEVHR-UHFFFAOYSA-N 3-phenyl-1-piperidin-1-ylhexan-3-ol Chemical compound C=1C=CC=CC=1C(O)(CCC)CCN1CCCCC1 SFPOWKMTUKEVHR-UHFFFAOYSA-N 0.000 description 1
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 description 1
- FHTWNTKDXPHJFT-UHFFFAOYSA-N 6-methyl-3-phenyl-1-piperidin-1-ylheptan-3-ol Chemical compound C=1C=CC=CC=1C(O)(CCC(C)C)CCN1CCCCC1 FHTWNTKDXPHJFT-UHFFFAOYSA-N 0.000 description 1
- 229940035674 ANESTHETICS Drugs 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- WDIHJSXYQDMJHN-UHFFFAOYSA-L Barium chloride Chemical compound [Cl-].[Cl-].[Ba+2] WDIHJSXYQDMJHN-UHFFFAOYSA-L 0.000 description 1
- AQNQQHJNRPDOQV-UHFFFAOYSA-N Bromocyclohexane Chemical compound BrC1CCCCC1 AQNQQHJNRPDOQV-UHFFFAOYSA-N 0.000 description 1
- IQRIPSWGQBVWTK-UHFFFAOYSA-N C(CCC)CC(C(O)(C1=CC=CC=C1)C1CCCCC1)NCC Chemical compound C(CCC)CC(C(O)(C1=CC=CC=C1)C1CCCCC1)NCC IQRIPSWGQBVWTK-UHFFFAOYSA-N 0.000 description 1
- MIEFVQIJSAGPBZ-UHFFFAOYSA-N CCC[Mg] Chemical compound CCC[Mg] MIEFVQIJSAGPBZ-UHFFFAOYSA-N 0.000 description 1
- IQFVPQOLBLOTPF-HKXUKFGYSA-L Congo red Chemical compound [Na+].[Na+].C1=CC=CC2=C(N)C(/N=N/C3=CC=C(C=C3)C3=CC=C(C=C3)/N=N/C3=C(C4=CC=CC=C4C(=C3)S([O-])(=O)=O)N)=CC(S([O-])(=O)=O)=C21 IQFVPQOLBLOTPF-HKXUKFGYSA-L 0.000 description 1
- 241000071340 Juncus confusus Species 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- DGEZNRSVGBDHLK-UHFFFAOYSA-N [1,10]phenanthroline Chemical compound C1=CN=C2C3=NC=CC=C3C=CC2=C1 DGEZNRSVGBDHLK-UHFFFAOYSA-N 0.000 description 1
- WMJMABVHDMRMJA-UHFFFAOYSA-M [Cl-].[Mg+]C1CCCCC1 Chemical compound [Cl-].[Mg+]C1CCCCC1 WMJMABVHDMRMJA-UHFFFAOYSA-M 0.000 description 1
- QFYKHWFHKLUGAV-UHFFFAOYSA-N [Mg]C1CCCCC1 Chemical compound [Mg]C1CCCCC1 QFYKHWFHKLUGAV-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 229910001626 barium chloride Inorganic materials 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 125000000319 biphenyl-4-yl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- HELISQMWNRMVDD-UHFFFAOYSA-N bromocyclohexane;magnesium Chemical compound [Mg].BrC1CCCCC1 HELISQMWNRMVDD-UHFFFAOYSA-N 0.000 description 1
- 238000009903 catalytic hydrogenation reaction Methods 0.000 description 1
- 150000001860 citric acid derivatives Chemical class 0.000 description 1
- 238000005352 clarification Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000005712 crystallization Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 150000001983 dialkylethers Chemical class 0.000 description 1
- 125000004915 dibutylamino group Chemical group C(CCC)N(CCCC)* 0.000 description 1
- 125000001664 diethylamino group Chemical group [H]C([H])([H])C([H])([H])N(*)C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000001747 exhibiting Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- YKASHPSKFYVZRC-UHFFFAOYSA-M furan-2-ylmethyl(trimethyl)azanium;iodide Chemical compound [I-].C[N+](C)(C)CC1=CC=CO1 YKASHPSKFYVZRC-UHFFFAOYSA-M 0.000 description 1
- 125000002541 furyl group Chemical group 0.000 description 1
- 239000003193 general anesthetic agent Substances 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- 230000000977 initiatory Effects 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- GFTXWCQFWLOXAT-UHFFFAOYSA-M magnesium;cyclohexane;bromide Chemical compound [Mg+2].[Br-].C1CC[CH-]CC1 GFTXWCQFWLOXAT-UHFFFAOYSA-M 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000006011 modification reaction Methods 0.000 description 1
- 125000003136 n-heptyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
- AMQJEAYHLZJPGS-UHFFFAOYSA-N n-pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 description 1
- 239000005445 natural product Substances 0.000 description 1
- 230000002276 neurotropic Effects 0.000 description 1
- 150000002823 nitrates Chemical class 0.000 description 1
- 125000003261 o-tolyl group Chemical group [H]C1=C([H])C(*)=C(C([H])=C1[H])C([H])([H])[H] 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 101700076053 rle-1 Proteins 0.000 description 1
- 230000002048 spasmolytic Effects 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- 230000002588 toxic Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 125000005023 xylyl group Chemical group 0.000 description 1
Landscapes
- Hydrogenated Pyridines (AREA)
Publications (1)
Publication Number | Publication Date |
---|---|
BE477344A true BE477344A (pt) |
Family
ID=125436
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BE477344D BE477344A (pt) |
Country Status (1)
Country | Link |
---|---|
BE (1) | BE477344A (pt) |
-
0
- BE BE477344D patent/BE477344A/fr unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA1184180A (fr) | Derives de (quinolyl-2, ou -3 ou -4)-1 (piperidyl ou pyrrolidinyl-2 ou -3)-2 ou -3 ethanone ou propanone, procedes pour leur preparation, et leur utilisation comme medicaments | |
LU79761A1 (fr) | Procede de preparation de nouveaux composes de phtalazine et de composition pharmaceutique les contenant | |
EP0371876A1 (fr) | Composés isoxazoles et isoxazolines à activité anticonvulsivante, procédé de préparation et compositions thérapeutiques les contenant | |
EP0289380A1 (fr) | Dérivés d'aryl-hétéroaryl carbinols avec activité analgésique | |
EP0507672B1 (fr) | Dérivés de N-cyclohexyl benzamides, leurs préparations et leurs applications en thérapeutique | |
EP0110781A1 (fr) | (Amino-2 éthyl)-6 benzoxazolinones substituées, leur préparation et une composition pharmaceutique les contenant | |
FR2459248A1 (fr) | Hemi-esters du cholesterol utilisables en medecine et leur procede de fabrication | |
CH662122A5 (fr) | Derives organiques du germanium ayant simultanement un caractere hydrophile et lipophile et procede pour les preparer. | |
BE616646A (pt) | ||
FR2662692A1 (fr) | Derives heterocycliques doues d'activite anticonvulsivante, procede de preparation et composition pharmaceutique. | |
BE477344A (pt) | ||
FR2534915A1 (fr) | Nouveaux derives de 2-(phenoxymethyl)-morpholine, utilisation en therapeutique et procede de preparation | |
CA1211105A (fr) | Procede pour la preparation de derives de p-acylaminophenol et derives obtenus par ce procede | |
FR2653767A1 (fr) | Derives de 1-(aminophenyl)-2-piperidinopropanone, procede et utilisation en therapeutique. | |
CA1167444A (fr) | Derives de la chloro-3 quinoleine, procedes pour leur preparation, et leur utilisation comme medicaments | |
FR2491471A1 (fr) | Benzoxazolinones substituees, leur preparation et leur application en therapeutique | |
CH658786A5 (fr) | Medicaments qui contiennent d'alpha-(n-pyrrolyl)-acides ou de leurs sels ou esters. | |
CH633000A5 (fr) | Derives de benzamidine. | |
LU85296A1 (fr) | Procede de preparation de derives de pyrimidinetrione | |
CH392508A (fr) | Procédé de préparation d'esters de 3-phényl-3-pyrrolidinols | |
CA2038199A1 (fr) | Derives du 1,2,5,6-tetrahydropyridin-3-carboxaldehyde oxime, leur procede de preparation et leur application comme medicaments | |
BE877161A (fr) | Cycloalkultriazoles et leur procede de preparation | |
FR2473512A1 (fr) | Nouveaux 2-aminomethyl-6-halogeno-phenols, leur preparation et leur application comme medicaments | |
BE553401A (pt) | ||
BE558138A (pt) |